Galera Therapeutics, Inc. (GRTX)
OTCMKTS
· Delayed Price · Currency is USD
0.0230
-0.0020 (-8.00%)
Apr 29, 2025, 2:15 PM EDT
Galera Therapeutics Employees
Galera Therapeutics had 3 employees as of December 31, 2024. The number of employees decreased by 4 or -57.14% compared to the previous year.
Employees
3
Change (1Y)
-4
Growth (1Y)
-57.14%
Revenue / Employee
n/a
Profits / Employee
-$6,319,000
Market Cap
1.68M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Galera Therapeutics News
- 4 months ago - Galera Therapeutics completes acquisition of Nova Pharmaceuticals - GlobeNewsWire
- 9 months ago - Galera Announces Board Approval of Complete Liquidation and Dissolution - GlobeNewsWire
- 1 year ago - Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Adopts Limited Duration Stockholder Rights Agreement - GlobeNewsWire
- 1 year ago - Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 1 year ago - Galera Announces Receipt of Type A Meeting Minutes and Strategic Update - GlobeNewsWire
- 1 year ago - Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem - GlobeNewsWire